InsidersTradesSigma
Explore the full directors' dealings record of Acorda Therapeutics, Inc., a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 20 March 2023 (Acquisition). Among the most active insiders: COHEN RON. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.